Prevention and reversal of atrial fibrillation inducibility and autonomic remodeling by low-level vagosympathetic nerve stimulation
- PMID: 21272747
- DOI: 10.1016/j.jacc.2010.09.034
Prevention and reversal of atrial fibrillation inducibility and autonomic remodeling by low-level vagosympathetic nerve stimulation
Abstract
Objectives: We hypothesized that autonomic atrial remodeling can be reversed by low-level (LL) vagosympathetic nerve stimulation (VNS).
Background: Previously, we showed that VNS can be antiarrhythmogenic.
Methods: Thirty-three dogs were subjected to electrical stimulation (20 Hz) applied to both vagosympathetic trunks at voltages 10% to 50% below the threshold that slowed sinus rate or AV conduction. Group 1 (n = 7): Programmed stimulation (PS) was performed at baseline and during 6-h rapid atrial pacing (RAP). PS allowed determination of effective refractory period (ERP) and AF inducibility measured by window of vulnerability (WOV). LL-VNS was continuously applied from the 4th to 6th hours. Group 2 (n = 4): After baseline ERP and WOV determinations, 6-h concomitant RAP+LL-VNS was applied. Sustained AF was induced by injecting acetylcholine (ACh) 10 mM into the anterior right ganglionated plexus (Group 3, n = 10) or applying ACh 10 mM to right atrial appendage (Group 4, n = 9).
Results: Group 1: The ERP progressively shortened and the ΣWOV (sum of WOV from all tested sites) progressively increased (p < 0.05) during 3-h RAP then returned toward baseline during 3-h RAP+LL-VNS (p < 0.05). Group 2: 6-h concomitant RAP+LL-VNS did not induce any significant change in ERP and ΣWOV. Group 3 and Group 4: AF duration (AF-D) and cycle length (AF-CL) were markedly altered by 3-h LL-VNS (Group 3: baseline: AF-D = 389 ± 90 s, AF-CL = 45.1 ± 7.8 ms; LL-VNS: AF-D = 50 ± 15 s, AF-CL = 82.0 ± 13.7 ms [both p < 0.001]; Group 4: baseline: AF-D = 505 ± 162 s, AF-CL = 48.8 ± 6.6 ms; LL-VNS: AF-D = 71 ± 21 s, AF-CL = 101.3 ± 20.9 ms [both p < 0.001]).
Conclusions: LL-VNS can prevent and reverse atrial remodeling induced by RAP as well as suppress AF induced by strong cholinergic stimulation. Inhibition of the intrinsic cardiac autonomic nervous system by LL-VNS may be responsible for these salutary results.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Vagus nerve stimulation: A spear role or a shield role in atrial fibrillation?Int J Cardiol. 2015 Nov 1;198:115-6. doi: 10.1016/j.ijcard.2015.06.171. Epub 2015 Jul 5. Int J Cardiol. 2015. PMID: 26184434 No abstract available.
Similar articles
-
Low-level vagosympathetic nerve stimulation inhibits atrial fibrillation inducibility: direct evidence by neural recordings from intrinsic cardiac ganglia.J Cardiovasc Electrophysiol. 2011 Apr;22(4):455-63. doi: 10.1111/j.1540-8167.2010.01908.x. Epub 2010 Oct 13. J Cardiovasc Electrophysiol. 2011. PMID: 20946225
-
Low-level carotid baroreflex stimulation suppresses atrial fibrillation by inhibiting left stellate ganglion activity in an acute canine model.Heart Rhythm. 2016 Nov;13(11):2203-2212. doi: 10.1016/j.hrthm.2016.08.021. Epub 2016 Aug 9. Heart Rhythm. 2016. PMID: 27520541
-
Low-level vagosympathetic stimulation: a paradox and potential new modality for the treatment of focal atrial fibrillation.Circ Arrhythm Electrophysiol. 2009 Dec;2(6):645-51. doi: 10.1161/CIRCEP.109.868331. Circ Arrhythm Electrophysiol. 2009. PMID: 19948505
-
Vagus Nerve Stimulation and Atrial Fibrillation: Revealing the Paradox.Neuromodulation. 2022 Apr;25(3):356-365. doi: 10.1016/j.neurom.2022.01.008. Epub 2022 Feb 19. Neuromodulation. 2022. PMID: 35190246 Review.
-
The role of low-level vagus nerve stimulation in cardiac therapy.Expert Rev Med Devices. 2019 Aug;16(8):675-682. doi: 10.1080/17434440.2019.1643234. Epub 2019 Jul 19. Expert Rev Med Devices. 2019. PMID: 31306049 Review.
Cited by
-
Low-Level Tragus Stimulation Modulates Atrial Alternans and Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation.J Am Heart Assoc. 2021 Jun 15;10(12):e020865. doi: 10.1161/JAHA.120.020865. Epub 2021 Jun 2. J Am Heart Assoc. 2021. PMID: 34075778 Free PMC article. Clinical Trial.
-
Vagus Nerve Stimulation and the Cardiovascular System.Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):a034173. doi: 10.1101/cshperspect.a034173. Cold Spring Harb Perspect Med. 2020. PMID: 31109966 Free PMC article. Review.
-
Neuromodulatory Approaches for Atrial Fibrillation Ablation.Eur Cardiol. 2021 Dec 9;16:e53. doi: 10.15420/ecr.2021.05. eCollection 2021 Feb. Eur Cardiol. 2021. PMID: 35024055 Free PMC article. Review.
-
Non-invasive Autonomic Neuromodulation Is Opening New Landscapes for Cardiovascular Diseases.Front Physiol. 2020 Dec 15;11:550578. doi: 10.3389/fphys.2020.550578. eCollection 2020. Front Physiol. 2020. PMID: 33384606 Free PMC article.
-
Neuromodulation of the Cardiac Autonomic Nervous System for Arrhythmia Treatment.Biomedicines. 2025 Jul 21;13(7):1776. doi: 10.3390/biomedicines13071776. Biomedicines. 2025. PMID: 40722846 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical